Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Crohn Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Crohn Diseasemarket, defines the market attractiveness level of Crohn Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Crohn Disease industry, describes the types of Crohn Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Crohn Disease market and the development prospects and opportunities of Crohn Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Crohn Disease market in Chapter 13.
By Player:
AbbVie
Tillotts Pharma
UCB
Amgen
Janssen Biotech
Takeda Pharmaceuticals
By Type:
Aminosalicylates (5-ASA)
Corticosteroids
Immunomodulators
Antibiotics
By End-User:
Achieving remission (the absence of symptoms)
Maintaining remission (prevention of flare-ups)
Pediatric Crohn's Disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Crohn Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Crohn Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Crohn Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Crohn Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Crohn Disease Market Analysis and Outlook to 2022
-
7.1 Global Crohn Disease Consumption (2017-2022)
-
7.2 United States Crohn Disease Consumption (2017-2022)
-
7.3 Europe Crohn Disease Consumption (2017-2022)
-
7.4 China Crohn Disease Consumption (2017-2022)
-
7.5 Japan Crohn Disease Consumption (2017-2022)
-
7.6 India Crohn Disease Consumption (2017-2022)
-
7.7 South Korea Crohn Disease Consumption (2017-2022)
8 Region and Country-wise Crohn Disease Market Analysis and Outlook to 2028
-
8.1 Global Crohn Disease Consumption Forecast (2022-2028)
-
8.2 United States Crohn Disease Consumption Forecast (2022-2028)
-
8.3 Europe Crohn Disease Consumption Forecast (2022-2028)
-
8.4 China Crohn Disease Consumption Forecast (2022-2028)
-
8.5 Japan Crohn Disease Consumption Forecast (2022-2028)
-
8.6 India Crohn Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Crohn Disease Consumption Forecast (2022-2028)
9 Global Crohn Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Crohn Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Aminosalicylates (5-ASA) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antibiotics Consumption and Growth Rate (2017-2022)
-
9.2 Global Crohn Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Achieving remission (the absence of symptoms) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Maintaining remission (prevention of flare-ups) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pediatric Crohn's Disease Consumption and Growth Rate (2017-2022)
10 Global Crohn Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Crohn Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Aminosalicylates (5-ASA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Crohn Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Achieving remission (the absence of symptoms) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Maintaining remission (prevention of flare-ups) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Pediatric Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Crohn Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Crohn Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Crohn Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Crohn Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Crohn Disease Market Competitive Analysis
-
14.1 AbbVie
-
14.1.1 AbbVie Company Details
-
14.1.2 AbbVie Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AbbVie Crohn Disease Product and Service
-
14.2 Tillotts Pharma
-
14.2.1 Tillotts Pharma Company Details
-
14.2.2 Tillotts Pharma Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Tillotts Pharma Crohn Disease Product and Service
-
14.3 UCB
-
14.3.1 UCB Company Details
-
14.3.2 UCB Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 UCB Crohn Disease Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Crohn Disease Product and Service
-
14.5 Janssen Biotech
-
14.5.1 Janssen Biotech Company Details
-
14.5.2 Janssen Biotech Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Janssen Biotech Crohn Disease Product and Service
-
14.6 Takeda Pharmaceuticals
-
14.6.1 Takeda Pharmaceuticals Company Details
-
14.6.2 Takeda Pharmaceuticals Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceuticals Crohn Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Crohn Disease
-
Figure Crohn Disease Picture
-
Table Global Crohn Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Crohn Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Crohn Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Crohn Disease Consumption by Country (2017-2022)
-
Figure United States Crohn Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Crohn Disease Consumption and Growth Rate (2017-2022)
-
Figure China Crohn Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Crohn Disease Consumption and Growth Rate (2017-2022)
-
Figure India Crohn Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Crohn Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Crohn Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Crohn Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Crohn Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Crohn Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Crohn Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Crohn Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aminosalicylates (5-ASA) Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
Figure Global Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Achieving remission (the absence of symptoms) Consumption and Growth Rate (2017-2022)
-
Figure Global Maintaining remission (prevention of flare-ups) Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Crohn's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Aminosalicylates (5-ASA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Achieving remission (the absence of symptoms) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Maintaining remission (prevention of flare-ups) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Crohn Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Crohn Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Crohn Disease Product and Service
-
Table Tillotts Pharma (Foundation Year, Company Profile and etc.)
-
Table Tillotts Pharma Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tillotts Pharma Crohn Disease Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Crohn Disease Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Crohn Disease Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Crohn Disease Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Crohn Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Crohn Disease Product and Service
-
